Andy Jordan
Business Management
SPYRYX Bioscience
Australia
Biography
Mr. Jordan is a retired senior executive with extensive experience in building, financing, and governance of technology and healthcare companies, who has been involved as a consultant and Director in the establishment of Spyryx. In addition to spending 20 years as a CPA in public accounting at KPMG focused on mergers, acquisitions, and fund-raising for early to mid- stage tech and biotech companies, he has served as Chief Financial Officer and Chief Business Officer for a number of biopharmaceutical and medical device companies. Following his career at KPMG, Mr. Jordan joined Guilford Pharmaceuticals, a company he helped found and take public as CFO. During his tenure at Guilford, the company raised $500 million in capital and launched several FDA-approved products. Subsequent to Guilford, Mr. Jordan served as CFO of Odyssey Pharmaceuticals, a commercial-stage specialty pharmaceutical company, and CFO/CBO of Infraredx, an interventional cardiology device company. Further to his operating roles, he was also a member of the board of directors and chair of the audit committee for Gemin X Pharmaceuticals, prior to its acquisition by Cephalon. Mr. Jordan received his BA from Rutgers College and his MBA from Rutgers Graduate School of Business.
Research Interest
Business Management
